Immunoblotting showed that Cdc20 was highly expressed in 786-O, A498, and ACHN among cell lines in kidney cancer, and in PC3 of 4 prostate cancer cell lines, and NCI-H1299 and PC-9 of 6 lung cancer cell lines (Figures D-F). Here, CDC20 is linked to lung carcinoma.